[Staging of oropharyngeal carcinomas : New TNM classification as a challenge for head and neck cancer centers].
CONCLUSION: Clinical trials will have to show whether deescalation strategies regarding p16-positive carcinomas are supported by the changes made in the TNM staging system. A prospective multicenter study should examine the universal applicability, the appropriateness for all sublocations, as well as the prognostic significance of the current edition.
PMID: 29536123 [PubMed - as supplied by publisher]
Source: HNO - Category: ENT & OMF Tags: HNO Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Clinical Trials | Databases & Libraries | ENT & OMF | Head and Neck Cancer | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Smokers | Study